These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 326604)
1. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Faber OK; Binder C Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon. Hendriksen C; Faber OK; Drejer J; Binder C Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408 [TBL] [Abstract][Full Text] [Related]
3. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal. Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876 [TBL] [Abstract][Full Text] [Related]
4. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877 [TBL] [Abstract][Full Text] [Related]
5. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Madsbad S; Krarup T; McNair P; Christiansen C; Faber OK; Transbøl I; Binder C Acta Med Scand; 1981; 210(3):153-6. PubMed ID: 7027749 [TBL] [Abstract][Full Text] [Related]
6. C-peptide response to glucagon in young diabetics. Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232 [TBL] [Abstract][Full Text] [Related]
8. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function. Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069 [TBL] [Abstract][Full Text] [Related]
9. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306 [TBL] [Abstract][Full Text] [Related]
10. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus. Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582 [TBL] [Abstract][Full Text] [Related]
11. Reproducibility of the glucagon test. Arnold-Larsen S; Madsbad S; Kühl C Diabet Med; 1987; 4(4):299-303. PubMed ID: 2956039 [TBL] [Abstract][Full Text] [Related]
12. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism. Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209 [TBL] [Abstract][Full Text] [Related]
13. The effect of acute hyperglycemia on the plasma C-peptide response to intravenous glucagon or to a mixed meal in insulin-dependent diabetes mellitus. Gjessing HJ; Reinholdt B; Faber OK; Pedersen O Acta Endocrinol (Copenh); 1991 May; 124(5):556-62. PubMed ID: 2028714 [TBL] [Abstract][Full Text] [Related]
14. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Bolli G; de Feo P; Compagnucci P; Cartechini MG; Angeletti G; Santeusanio F; Brunetti P; Gerich JE Diabetes; 1983 Feb; 32(2):134-41. PubMed ID: 6337896 [TBL] [Abstract][Full Text] [Related]
15. C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide. Mirel RD; Ginsberg-Fellner F; Horwitz DL; Rayfield EJ Diabetologia; 1980 Sep; 19(3):183-8. PubMed ID: 6997119 [TBL] [Abstract][Full Text] [Related]
16. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511 [TBL] [Abstract][Full Text] [Related]
17. C-peptide measurement and its clinical usefulness: a review. Bonser AM; Garcia-Webb P Ann Clin Biochem; 1981 Jul; 18(Pt 4):200-6. PubMed ID: 7025733 [No Abstract] [Full Text] [Related]
18. Residual pancreatic function in insulin dependent diabetics. Glatthaar C; Beaven DW; Donald RA; Smith JR; Espiner EA Aust N Z J Med; 1982 Feb; 12(1):43-7. PubMed ID: 7044357 [TBL] [Abstract][Full Text] [Related]
19. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man. Sakai T; Ohneda A; Nihei J; Kobayashi T Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899 [TBL] [Abstract][Full Text] [Related]
20. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus. Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]